PCSS wanted to share this email from the federal Drug Enforcement Agency regarding new training requirements.
Requirements for training for Medication Assistant Treatment as part of the MATE Act
Dear DEA Registrant:
Please see the letter which outlines the requirements for training for Medication Assistant Treatment as part of the MATE Act, which was part of the Omnibus Bill at the end of December 2022. DEA was given 90 days to let practitioners know how to meet the MATE Act’s training requirement which is tied to their initial or renewal DEA registration beginning on June 27, 2023. This letter provides the information to the practitioners as to how they can meet those training requirements. It will be posted to our website at the following link: Informational Documents.
- DEA Letter outlining training requirements for Medication Assistant Treatment
- SAMHSA’s MATE guidance document
- Updated DEA Registration Certificate after Removal of X-Waiver
- Elimination of Patient Limits for Prescribing Buprenorphine for Treatment of Opioid Use Disorder (OUD) under the Consolidated Appropriations Act (CAA) of 2023
- DEA Diversion Guidance Document Portal
- DEA Diversion Q&A Page
Please contact the Diversion Control Division Policy Section at [email protected] if you seek additional assistance.